Overall, these findings further corroborate the notion of p140Cap as a tumor suppressor in BC and point to a possible involvement of p140Cap in influencing the TME immune infiltrate and the anti-tumor inflammatory response in BC patients. This evidence concerns the gene SRCIN1 and breast cancer.